Overview
Greenberg dysplasia, also known as hydrops-ectopic calcification-moth-eaten (HEM) skeletal dysplasia, is an extremely rare and lethal autosomal recessive skeletal disorder. It is caused by mutations in the LBR (lamin B receptor) gene, which encodes an enzyme involved in cholesterol biosynthesis (sterol-14-reductase). The disease is characterized by severe fetal hydrops (abnormal fluid accumulation in multiple body compartments), markedly disorganized skeletal development, and a distinctive "moth-eaten" radiographic appearance of the long bones due to ectopic calcification within cartilage. Other key features include severe shortening of the limbs (micromelia), platyspondyly (flattened vertebral bodies), and disorganized chondro-osseous development. Greenberg dysplasia presents prenatally and is invariably lethal, with affected fetuses typically dying in the second or third trimester of pregnancy or at birth. The condition affects the skeletal system profoundly, with abnormal endochondral ossification and widespread ectopic calcifications throughout the skeleton. Severe non-immune hydrops fetalis is a hallmark finding. The radiographic moth-eaten pattern of bones is a distinctive diagnostic feature that helps differentiate this condition from other lethal skeletal dysplasias. There is no treatment or cure for Greenberg dysplasia due to its uniformly lethal nature. Management is limited to supportive care and genetic counseling for affected families. Prenatal diagnosis may be possible through ultrasound findings of hydrops and skeletal abnormalities, and can be confirmed by molecular genetic testing of the LBR gene. Carrier testing and prenatal molecular diagnosis are available for families with a known pathogenic variant. Fewer than 30 cases have been reported in the medical literature.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Greenberg dysplasia.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Greenberg dysplasia at this time.
New trials open frequently. Follow this disease to get notified.
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Greenberg dysplasia.
Community
No community posts yet. Be the first to share your experience with Greenberg dysplasia.
Start the conversation →Latest news about Greenberg dysplasia
No recent news articles for Greenberg dysplasia.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Greenberg dysplasia
What is Greenberg dysplasia?
Greenberg dysplasia, also known as hydrops-ectopic calcification-moth-eaten (HEM) skeletal dysplasia, is an extremely rare and lethal autosomal recessive skeletal disorder. It is caused by mutations in the LBR (lamin B receptor) gene, which encodes an enzyme involved in cholesterol biosynthesis (sterol-14-reductase). The disease is characterized by severe fetal hydrops (abnormal fluid accumulation in multiple body compartments), markedly disorganized skeletal development, and a distinctive "moth-eaten" radiographic appearance of the long bones due to ectopic calcification within cartilage. Oth
How is Greenberg dysplasia inherited?
Greenberg dysplasia follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Greenberg dysplasia typically begin?
Typical onset of Greenberg dysplasia is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Greenberg dysplasia?
1 specialists and care centers treating Greenberg dysplasia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.